Q3 2024 13F Holders as of 9/30/2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
227M
-
Number of holders
-
100
-
Total 13F shares, excl. options
-
175M
-
Shares change
-
-21.4M
-
Total reported value, excl. options
-
$173M
-
Value change
-
-$19.9M
-
Put/Call ratio
-
1.21
-
Number of buys
-
39
-
Number of sells
-
-38
-
Price
-
$0.99
Significant Holders of Gossamer Bio, Inc. - Common Stock (GOSS) as of Q3 2024
118 filings reported holding GOSS - Gossamer Bio, Inc. - Common Stock as of Q3 2024.
Gossamer Bio, Inc. - Common Stock (GOSS) has 100 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 175M shares
of 227M outstanding shares and own 76.93% of the company stock.
Largest 10 shareholders include NEA Management Company, LLC (18.1M shares), Siren, L.L.C. (13.3M shares), VANGUARD GROUP INC (11.8M shares), Octagon Capital Advisors LP (9.19M shares), ARCH Venture Management, LLC (8.06M shares), FMR LLC (7.94M shares), PRICE T ROWE ASSOCIATES INC /MD/ (6.43M shares), Palo Alto Investors LP (6.28M shares), Samsara BioCapital, LLC (6.13M shares), and 683 Capital Management, LLC (5.8M shares).
This table shows the top 100 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.